Clinical

Dataset Information

0

Study of CS-7017 in Combination With FOLFIRI in Subjects With Metastatic Colorectal Cancer Who Failed First-Line Therapy


ABSTRACT: This phase 2, randomized, active-controlled, open-label, parallel group, multicenter study will be conducted at up to 18 study centers in the US, Central America, and South America. Adult subjects with metastatic colorectal cancer (CRC) who failed first-line chemotherapy will participate in the study, which will be conducted on an outpatient basis. It is anticipated that 100 subjects will be enrolled to obtain approximately 90 evaluable subjects.

DISEASE(S): Neoplasms, Colorectal,Colorectal Cancer,Colorectal Neoplasms,Malignant Neoplasm Of Colon

PROVIDER: 2077298 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2014-03-25 | GSE56153 | GEO
| PRJNA972128 | ENA
2023-03-10 | PXD028476 | Pride
2015-07-20 | GSE70987 | GEO
2024-11-13 | GSE274767 | GEO
2014-03-25 | E-GEOD-56153 | biostudies-arrayexpress
| PRJEB28961 | ENA
2024-11-13 | GSE274766 | GEO
| PRJNA1037139 | ENA
2022-08-12 | PXD033177 | Pride